Literature DB >> 26183035

Surgical trauma induces postoperative T-cell dysfunction in lung cancer patients through the programmed death-1 pathway.

Pingbo Xu1, Ping Zhang2, Zhirong Sun1, Yun Wang1, Jiawei Chen1, Changhong Miao3.   

Abstract

The programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) pathway have been shown to be involved in tumor-induced and sepsis-induced immunosuppression. However, whether this pathway is involved in the surgery-induced dysfunction of T lymphocytes is not known. Here, we analyzed expression of PD-1 and PD-L1 on human peripheral mononuclear cells during the perioperative period. We found that surgery increased PD-1/PD-L1 expression on immune cells, which was correlated with the severity of surgical trauma. The count of T lymphocytes and natural killer cells reduced after surgery, probably due to the increased activity of caspase-3. Caspase-3 level was positively correlated with PD-1 expression. Profile of perioperative cytokines and hormones in plasma showed a significantly increased level of interferon-α, as well as various inflammatory cytokines and stress hormones. In ex vivo experiments, administration of anti-PD-1 antibody significantly ameliorated T-cell proliferation and partially reversed the T-cell apoptosis induced by surgical trauma. We provide evidences that surgical trauma can induce immunosuppression through the PD-1/PD-L1 pathway. This pathway could be a target for preventing postoperative cellular immunosuppression.

Entities:  

Keywords:  Immunosuppression; Lung cancer; PD-1/PD-L1; Surgery

Mesh:

Substances:

Year:  2015        PMID: 26183035     DOI: 10.1007/s00262-015-1740-2

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  9 in total

1.  Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer.

Authors:  Robert S Svatek; Niannian Ji; Essel de Leon; Neelam Z Mukherjee; Aashish Kabra; Vincent Hurez; Marlo Nicolas; Joel E Michalek; Martin Javors; Karen Wheeler; Z Dave Sharp; Carolina B Livi; Zhen-Ju Shu; David Henkes; Tyler J Curiel
Journal:  Cancer Immunol Res       Date:  2018-12-18       Impact factor: 11.151

2.  Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study.

Authors:  Xiaoyu Zheng; Yu Wang; Linlin Dong; Su Zhao; Liping Wang; Hong Chen; Yang Xu; Guonian Wang
Journal:  Onco Targets Ther       Date:  2018-03-01       Impact factor: 4.147

Review 3.  Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies.

Authors:  Fan Tang; Yan Tie; Chongqi Tu; Xiawei Wei
Journal:  Clin Transl Med       Date:  2020-01

Review 4.  Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity.

Authors:  Orneala Bakos; Christine Lawson; Samuel Rouleau; Lee-Hwa Tai
Journal:  J Immunother Cancer       Date:  2018-09-03       Impact factor: 13.751

Review 5.  Late immune consequences of combat trauma: a review of trauma-related immune dysfunction and potential therapies.

Authors:  Kelly B Thompson; Luke T Krispinsky; Ryan J Stark
Journal:  Mil Med Res       Date:  2019-04-24

Review 6.  Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer.

Authors:  Bin Qiu; Kaican Cai; Chun Chen; Jun Chen; Ke-Neng Chen; Qi-Xun Chen; Chao Cheng; Tian-Yang Dai; Junqiang Fan; Zhaohui Fan; Jian Hu; Wei-Dong Hu; Yun-Chao Huang; Ge-Ning Jiang; Jie Jiang; Tao Jiang; Wen-Jie Jiao; He-Cheng Li; Qiang Li; Yong-De Liao; Hong-Xu Liu; Jun-Feng Liu; Lunxu Liu; Yang Liu; Hao Long; Qing-Quan Luo; Hai-Tao Ma; Nai-Quan Mao; Xiao-Jie Pan; Fengwei Tan; Li-Jie Tan; Hui Tian; Dong Wang; Wen-Xiang Wang; Li Wei; Nan Wu; Qing-Chen Wu; Jiaqing Xiang; Shi-Dong Xu; Lin Yang; Hao Zhang; Lanjun Zhang; Peng Zhang; Yi Zhang; Zhenfa Zhang; Kunshou Zhu; Yuming Zhu; Sang-Won Um; In-Jae Oh; Yusuke Tomita; Satoshi Watanabe; Takeo Nakada; Nobuhiko Seki; Toyoaki Hida; Shinji Sasada; Junji Uchino; Haruhiko Sugimura; Said Dermime; Federico Cappuzzo; Stefania Rizzo; William Chi-Shing Cho; Pierfilippo Crucitti; Filippo Longo; Kye Young Lee; Dirk De Ruysscher; Ben G L Vanneste; Muhammad Furqan; Jessica C Sieren; Sai Yendamuri; Kenneth W Merrell; Julian R Molina; Giulio Metro; Raffaele Califano; Stefano Bongiolatti; Mariano Provencio; Paul Hofman; Shugeng Gao; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-09

7.  The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.

Authors:  Miao-Fen Chen; Ping-Tsung Chen; Wen-Cheng Chen; Ming-Shian Lu; Paul-Yang Lin; Kuan Der Lee
Journal:  Oncotarget       Date:  2016-02-16

Review 8.  Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence.

Authors:  Ryungsa Kim
Journal:  J Transl Med       Date:  2018-01-18       Impact factor: 5.531

9.  Effect of selective lymph node dissection on immune function in patients with T1 stage non-small cell lung cancer: a randomized controlled trial.

Authors:  Jin-Long Zhao; Yun-Qiang Nie; Peng Yang; Da-Zhi Jiang; Feng-Wei Zhang
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.